JPWO2022251217A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022251217A5 JPWO2022251217A5 JP2023572959A JP2023572959A JPWO2022251217A5 JP WO2022251217 A5 JPWO2022251217 A5 JP WO2022251217A5 JP 2023572959 A JP2023572959 A JP 2023572959A JP 2023572959 A JP2023572959 A JP 2023572959A JP WO2022251217 A5 JPWO2022251217 A5 JP WO2022251217A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163202029P | 2021-05-24 | 2021-05-24 | |
| US63/202,029 | 2021-05-24 | ||
| PCT/US2022/030727 WO2022251217A2 (en) | 2021-05-24 | 2022-05-24 | Ciita targeting zinc finger nucleases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520462A JP2024520462A (en) | 2024-05-24 |
| JPWO2022251217A5 true JPWO2022251217A5 (en) | 2024-06-10 |
Family
ID=84230341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572959A Pending JP2024520462A (en) | 2021-05-24 | 2022-05-24 | CIITA targeting zinc finger nucleases |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240301375A1 (en) |
| EP (1) | EP4347810A2 (en) |
| JP (1) | JP2024520462A (en) |
| KR (1) | KR20240011184A (en) |
| CN (1) | CN117597439A (en) |
| AU (1) | AU2022281328A1 (en) |
| CA (1) | CA3219830A1 (en) |
| IL (1) | IL308845A (en) |
| WO (1) | WO2022251217A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102013111099B4 (en) * | 2013-10-08 | 2023-11-30 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Permanent gene correction using nucleotide-modified messenger RNA |
| WO2018132783A1 (en) * | 2017-01-13 | 2018-07-19 | The Regents Of The University Of California | Immunoengineered pluripotent cells |
| JP7356354B2 (en) * | 2017-05-12 | 2023-10-04 | クリスパー セラピューティクス アクチェンゲゼルシャフト | Materials and methods for the manipulation of cells and their use in immuno-oncology |
| US11512287B2 (en) * | 2017-06-16 | 2022-11-29 | Sangamo Therapeutics, Inc. | Targeted disruption of T cell and/or HLA receptors |
-
2022
- 2022-05-24 JP JP2023572959A patent/JP2024520462A/en active Pending
- 2022-05-24 WO PCT/US2022/030727 patent/WO2022251217A2/en active Application Filing
- 2022-05-24 IL IL308845A patent/IL308845A/en unknown
- 2022-05-24 CA CA3219830A patent/CA3219830A1/en active Pending
- 2022-05-24 KR KR1020237044444A patent/KR20240011184A/en unknown
- 2022-05-24 EP EP22811985.5A patent/EP4347810A2/en active Pending
- 2022-05-24 US US18/563,741 patent/US20240301375A1/en active Pending
- 2022-05-24 AU AU2022281328A patent/AU2022281328A1/en active Pending
- 2022-05-24 CN CN202280045507.1A patent/CN117597439A/en active Pending